Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
ANKELIFE
company
About
ANKELIFE specializes in the research, development, and production of genetic engineering drugs in the cosmetics field.
- 1 - 10
Highlights
Details
- Last Funding Type
- Series A
- Last Funding Money Raised
- ¥10M
- Industries
- Biotechnology,Cosmetics,Health Care,Pharmaceutical,Product Research
- Founded date
- Mar 28, 2014
- Number Of Employee
- 1 - 10
- Operating Status
- Active
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
¥33M
ANKELIFE has raised a total of
¥33M
in funding over 2 rounds. Their latest funding was raised on
Aug 2, 2017 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Aug 2, 2017 | Series B | ¥20M | 1 |
Hefei Hi-Tech Venture Capital
|
— | Detail |
| Oct 14, 2016 | Series A | ¥10M | 1 |
Zhongan Health
|
— | Detail |
| Oct 27, 2015 | Angel | ¥3M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
2
3
ANKELIFE is funded by 3 investors.
Hefei Hi-Tech Venture Capital
and Zhongan Health
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Hefei Hi-Tech Venture Capital
|
Yes | Series B |
|
Zhongan Health
|
Yes | Series A |
|
|
— | Angel |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
